Blueprint Medicines
Edit

Blueprint Medicines

https://www.blueprintmedicines.com/
Last activity: 26.02.2023
Categories: BusinessPlatformManagementLocalLEDLearnHumanHealthTechDrugDesign
Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines to patients in the United States and Europe, and we are advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and hematologic disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.
Followers
22.2K
Website visits
55.2K /mo.
Mentions
66
Location: United States, Massachusetts, Cambridge
Employees: 501-1000
Total raised: $115M
Founded date: 2011
Founders name: Chris Varma
Founders Related Locations: United States, California, San Francisco

Investors 6

Funding Rounds 3

DateSeriesAmountInvestors
12.11.2014Series C$50M-
08.01.2014Series B$25M-
11.04.2011Series A$40M-

Mentions in press and media 66

DateTitleDescriptionSource
26.02.2023Blueprint Medicines Presents Registrational Data from PIONEE...-- AYVAKIT achieved a statistically significant and clinically meaningful improvement in total sympt...einpresswi...
09.01.2023Healthcare Hires of NoteProofPilot, a digital protocol automation platform for clinical trials, has added Bernadette Tosti t...medcitynew...
14.10.2022Taking Charge of a Cancer Diagnosis With Biomarker Testing(BPT) - David was in his thirties and living a healthy life when doctors discovered a cancerous mass...salamancap...
02.08.2022Investing in IDRxHIV ravaged entire communities before antiretroviral cocktail therapies helped turn the tide. Cockta...a16z.com/2...
10.06.2022Blue­print Med­i­cines slips as it changes end­point for tri...Blue­print is forg­ing ahead on its slow crawl to broad­en its mar­ket for Ay­vak­it. Hav­ing nabbe...endpts.com...
28.01.2022Blueprint Medicines' AYVAKYT® (avapritinib) Receives Positiv...CAMBRIDGE, Mass., Jan. 28, 2022 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today...marketscre...
29.11.2021Blueprint Medicines : to Expand Precision Therapy Leadership...Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo...marketscre...
28.10.2021Blueprint Medicines Reports Third Quarter 2021 Financial Res...Blueprint Medicines Reports Third Quarter 2021 Financial Results -- Strong AYVAKIT launch in advanc...marketscre...
03.09.2021Blueprint Medicines Announces Inducement Grants Under NASDAQ... CAMBRIDGE, Mass., Sept. 3, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a ...prnewswire...
04.08.2021Blueprint Medicines Announces Inducement Grants Under NASDAQ... CAMBRIDGE, Mass., Aug. 4, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) toda...prnewswire...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In